News in brief: Revised VITT advice from health dept; Mandatory vaccination needed for all hospital staff; Call for consistent OS benefit reporting on oncology drugs;

Revised VITT advice for primary care The Department of Health has released guidance for GPs on the management of thrombosis with thrombocytopenia syndrome after COVID-19 AstraZeneca vaccine. The recommendations differ slightly from the multidisciplinary guidance issued by the Thrombosis and Haemostasis Society of Australia and New Zealand vaccine-induced immune thrombotic thrombocytopenia (VITT) syndrome Communications Committee ...

Already a member?

Login to keep reading.

© 2021 the limbic